These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 32028805)

  • 1. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
    Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
    Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.
    Wang J; Ma W; Guo Q; Li Y; Hu Z; Zhu Z; Wang X; Zhao Y; Chai X; Tu P
    Int J Nanomedicine; 2016; 11():5851-5870. PubMed ID: 27853369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment.
    Chowdhury N; Chaudhry S; Hall N; Olverson G; Zhang QJ; Mandal T; Dash S; Kundu A
    AAPS PharmSciTech; 2020 Jul; 21(6):202. PubMed ID: 32696338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.
    Wi TI; Won JE; Lee CM; Lee JW; Kang TH; Shin BC; Han HD; Park YM
    Int J Nanomedicine; 2020; 15():8427-8436. PubMed ID: 33149585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin.
    Jiang K; Song X; Yang L; Li L; Wan Z; Sun X; Gong T; Lin Q; Zhang Z
    J Control Release; 2018 Feb; 271():21-30. PubMed ID: 29277681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy.
    Thomas E; Menon JU; Owen J; Skaripa-Koukelli I; Wallington S; Gray M; Mannaris C; Kersemans V; Allen D; Kinchesh P; Smart S; Carlisle R; Vallis KA
    Theranostics; 2019; 9(19):5595-5609. PubMed ID: 31534505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.
    Han NK; Shin DH; Kim JS; Weon KY; Jang CY; Kim JS
    Int J Nanomedicine; 2016; 11():1413-25. PubMed ID: 27103799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis.
    Ferreira Ddos S; Faria SD; Lopes SC; Teixeira CS; Malachias A; Magalhães-Paniago R; de Souza Filho JD; Oliveira BL; Guimarães AR; Caravan P; Ferreira LA; Alves RJ; Oliveira MC
    Int J Nanomedicine; 2016; 11():3737-51. PubMed ID: 27563241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the Inhibition of Breast Cancer Growth Through Synergistic Modulation of the Tumor Microenvironment Using Combined Nano-Delivery Systems.
    Wu J; Lu Q; Zhao J; Wu W; Wang Z; Yu G; Tian G; Gao Z; Wang Q
    Int J Nanomedicine; 2024; 19():5125-5138. PubMed ID: 38855730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.
    El-Dakdouki MH; Xia J; Zhu DC; Kavunja H; Grieshaber J; O'Reilly S; McCormick JJ; Huang X
    ACS Appl Mater Interfaces; 2014 Jan; 6(1):697-705. PubMed ID: 24308364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid nanoparticles for targeted oral delivery of doxorubicin: Lymphatic transport and CD44 engagement.
    Wu Y; Li J; Liu L; Chu X; Zhong M; Li H; Zhao C; Fu H; Sun Y; Li Y
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):133063. PubMed ID: 38880443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of ROS-Responsive Hyaluronic Acid Modified Paclitaxel and Diosgenin Liposomes and Study on Synergistic Enhancement of Anti-Ovarian Cancer Efficacy.
    Tang L; Wang YJ; Wang YY; Li ST; Kong L; Li XT; Ma LL; Liu XX
    Int J Nanomedicine; 2024; 19():5193-5211. PubMed ID: 38859958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.
    Shnaikat SG; Shakya AK; Bardaweel SK
    Saudi Pharm J; 2024 Jul; 32(7):102099. PubMed ID: 38817822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer.
    Ke X; Lin W; Li X; Wang H; Xiao X; Guo Z
    Drug Deliv; 2017 Nov; 24(1):1680-1689. PubMed ID: 29092646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the Inhibitory Effect of Doxorubicin-loaded Liposomes Targeting GFAP for Glioma Cells.
    Li Q; Xu J
    Anticancer Agents Med Chem; 2024; 24(3):177-184. PubMed ID: 37936466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
    Gupta B; Torchilin VP
    Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome.
    de Oliveira Silva J; Fernandes RS; de Alcântara Lemos J; Cassali GD; de Paula Sabino A; Townsend DM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2023 Sep; 165():115280. PubMed ID: 37541172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.
    Doddapaneni R; Patel K; Owaid IH; Singh M
    Drug Deliv; 2016 May; 23(4):1232-41. PubMed ID: 26701717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.